InnoCan Pharma Corporation (INNPF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.9 Million | -6.06 Million | -6.62 Million | -3.68 Million | -2.71 Million | -909 Thousand |
| Net Income | -4.7 Million | -3.88 Million | -10.09 Million | -9.95 Million | -3.33 Million | -1.19 Million |
| Depreciation & Amortization | 33 Thousand | 35 Thousand | 43 Thousand | 40 Thousand | 23 Thousand | - |
| Deferred income taxes | -1.87 Million | -2.77 Million | 2.3 Million | 5.24 Million | 294 Thousand | - |
| Stock-based compensation | 854 Thousand | 967 Thousand | 2.16 Million | 527 Thousand | 426 Thousand | 57 Thousand |
| Change in working capital | -810 Thousand | -531 Thousand | -969 Thousand | 474 Thousand | -127 Thousand | 125 Thousand |
| Other non-cash items | 719 Thousand | 125 Thousand | -83 Thousand | -24 Thousand | 4000.00 | 101 Thousand |
| Investing Cash Flow | -84 Thousand | -31 Thousand | -48 Thousand | - | -9000.00 | -3000.00 |
| Investments in PPE | -46 Thousand | -26 Thousand | -41 Thousand | - | -9000.00 | -3000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -6938.41 | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -38 Thousand | -5000.00 | -61.59 | - | - | - |
| Financing Cash Flow | 2.91 Million | 125 Thousand | 15.3 Million | 4.02 Million | 4.45 Million | 1.11 Million |
| Debt repayment | -22 Thousand | -11 Thousand | -38 Thousand | -39 Thousand | -38 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.99 Million | 130.61 Thousand | 3.91 Million | 3.62 Million | 4.49 Million | 1.11 Million |
| Other Financing Activities | 2.93 Million | 5389.00 | 11.42 Million | 439 Thousand | 4.45 Million | 1.91 Million |
| Accounts receivables | -2000.00 | -15 Thousand | 2000.00 | -2000.00 | -63 Thousand | -263 Thousand |
| Accounts payables | 17.31 Thousand | 42 Thousand | -474 Thousand | 500 Thousand | 27 Thousand | - |
| Inventory | -616 Thousand | -621 Thousand | -79 Thousand | -430 Thousand | - | - |
| Other working capital | -192 Thousand | 63 Thousand | -418 Thousand | 406 Thousand | -91 Thousand | 388 Thousand |
| Cash at beginning of period | 4.94 Million | 11.04 Million | 2.33 Million | 1.97 Million | 214 Thousand | 6000.00 |
| Cash at end of period | 3.88 Million | 4.94 Million | 11.04 Million | 2.33 Million | 1.97 Million | 214 Thousand |
| Capital Expenditure | -46 Thousand | -26 Thousand | -41 Thousand | - | -9000.00 | -3000.00 |
| Effect of forex changes on cash | 9000.00 | -128 Thousand | 84 Thousand | 28 Thousand | 29 Thousand | 2000.00 |
| Net cash flow / Change in cash | -1.06 Million | -6.1 Million | 8.71 Million | 365 Thousand | 1.75 Million | 208 Thousand |
| Free Cash Flow | -3.95 Million | -6.09 Million | -6.67 Million | -3.68 Million | -2.72 Million | -912 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 336.93 Thousand | -1.75 Million | -4.78 Million | -907.4 Thousand | -1.82 Million | -397 Thousand |
| Depreciation & Amortization | 9997.94 | 9955.33 | 33.6 Thousand | 8221.11 | 9000.00 | 9000.00 |
| Deferred income taxes | - | - | -1.87 Million | -556.42 Thousand | 650 Thousand | -1000.00 |
| Stock-based compensation | 378 Thousand | 1.15 Million | 854 Thousand | 99 Thousand | 561 Thousand | 61 Thousand |
| Change in working capital | 309.72 Thousand | -406.17 Thousand | -807.54 Thousand | -289.26 Thousand | -112 Thousand | -366 Thousand |
| Other non-cash items | -780.5 Thousand | 2.45 Million | 2.6 Million | 305.37 Thousand | 1000.00 | -19 Thousand |
| Investing Cash Flow | -2992.76 | -1991.07 | -53.97 Thousand | -9257.56 | -32 Thousand | -9000.00 |
| Investments in PPE | -2992.76 | -1991.07 | -46.84 Thousand | -9242.84 | -1000.00 | -9000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -7128.37 | -14.72 | -31 Thousand | 25.07 |
| Financing Cash Flow | 5621.29 | 1.44 Million | 2.97 Million | 1.17 Million | 1.44 Million | -6000.00 |
| Debt repayment | -5000.00 | -5000.00 | -22 Thousand | -31.5 Thousand | -5000.00 | -6000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 10.62 Thousand | 1.44 Million | 2.99 Million | 1.14 Million | 1.44 Million | -1300.03 |
| Other Financing Activities | -5000.09 | 1.45 Million | 2.93 Million | 1.12 Million | 1.45 Million | - |
| Accounts receivables | 957.98 Thousand | -539.57 Thousand | -344.19 Thousand | -150.09 Thousand | -5000.00 | -1000.00 |
| Accounts payables | -84.69 Thousand | 363.36 Thousand | 17.31 Thousand | -224.55 Thousand | 156 Thousand | -112 Thousand |
| Inventory | -64.81 Thousand | -851.18 Thousand | -627.29 Thousand | -66.33 Thousand | -266 Thousand | -136 Thousand |
| Other working capital | -498.75 Thousand | 621.21 Thousand | 146.64 Thousand | 151.72 Thousand | 3000.00 | -117 Thousand |
| Cash at beginning of period | 4.72 Million | 4 Million | 5.04 Million | 4.14 Million | 3.37 Million | 4.08 Million |
| Cash at end of period | 5.29 Million | 4.72 Million | 4 Million | 4 Million | 4.02 Million | 3.37 Million |
| Capital Expenditure | -2992.76 | -1991.07 | -46.84 Thousand | -9242.84 | -1000.00 | -9000.00 |
| Effect of forex changes on cash | -73 Thousand | 9000.00 | 9000.00 | 63 Thousand | -47 Thousand | 12 Thousand |
| Net cash flow / Change in cash | 566.1 Thousand | 724.7 Thousand | -1.04 Million | -145.6 Thousand | 651 Thousand | -716 Thousand |
| Free Cash Flow | 661.63 Thousand | -745.65 Thousand | -4.02 Million | -1.34 Million | -719 Thousand | -722 Thousand |
BABB
STN
ASP
GALT
CTRYY
EDD